✦ LIBER ✦

Microtubule-Associated Parameters as Predictive Markers of Docetaxel Activity in Advanced Breast Cancer Patients: Results of a Pilot Study

✍ Scribed by Chantal Bernard-Marty; Isabelle Treilleux; Charles Dumontet; Fatima Cardoso; Arlette Fellous; David Gancberg; Marie-Christine Bissery; Marianne Paesmans; Denis Larsimont; Martine J. Piccart; Angelo Di Leo

Book ID: 119934628
Publisher: CIG Media Group, LP.
Year: 2002
Tongue: English
Weight: 100 KB
Volume: 3
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2002.n.037

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of Microtubule Associated Par

Evaluation of Microtubule Associated Parameters (MTAPs) as predictive markers for Advanced Breast Cancer (ABC) patients treated with docetaxel

✍ C. Bernard; A. Fellous; A. Di Leo; I. Treilleux; D. Gancberg; M.J. Piccart; F. C 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 355 KB

Role of NF-kB as a prognostic marker in

Role of NF-kB as a prognostic marker in breast cancer: A pilot study in Indian patients

✍ Sarkar, Diptendra K.; Jana, Debarsi; Ganguly, Suvro 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Role of NF-κB as a Prognostic Marker in

Role of NF-κB as a Prognostic Marker in Breast Cancer : A Pilot Study in Indian Patients

✍ D. K. Sarkar, Debarshi Jana, P. S. Patil… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 245 KB

HER-2/neu as a Predictive Marker in a Po

HER-2/neu as a Predictive Marker in a Population of Advanced Breast Cancer Patients Randomly Treated Either with Single-agent Doxorubicin or Single-agent Docetaxel

✍ A. Di Leo; S. Chan; M. Paesmans; K. Friedrichs; T. Pinter; V. Cocquyt; E. Murray 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 268 KB

Gemcitabine, epirubicin and docetaxel as

Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study

✍ A. Schneeweiss; J. Huober; H.-P. Sinn; D. von Fournier; C. Rudlowski; F. Belderm 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 269 KB

Results of a phase II study of pemetrexe

Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer

✍ Nicholas J. Robert; Paul R. Conkling; Mark A. O’Rourke; Paul R. Kuefler; Kristi 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 234 KB